Brief: Q BioMed Inc Updates On COVID-19 Therapeutic Development And Clinical Trials
22/09/2021 14:58
Sept 22 (Reuters) - Q BioMed Inc QBIO.PK :
* Q BIOMED INC. UPDATES ON COVID-19 THERAPEUTIC DEVELOPMENT
AND
CLINICAL TRIALS - MAN-19 THERAPEUTIC PROGRAM HEADING TO CLINICAL
TRIAL IN EARLY 2022
Source text for Eikon: ID:nPn6HBJgna
Further company coverage: QBIO.PK
Recent news on Q BioMed
See all newsBrief: Q Biomed Inc. Chemotherapeutic Uttroside B, Receives Patent From United States Patent Office And Notice Of Allowance For Europe
Brief: Q Biomed Provides Shareholder Update
Brief: Q Biomed Announces Publication Of Research Showing Augmented Efficacy Of Its Drug Candidate Uttroside-B Against Liver Cancer
Brief: Q BioMed Inc Updates On COVID-19 Therapeutic Development And Clinical Trials
Brief: Q Biomed To Scale Up Production Of Uttroside-B